Resurrecting essential amino acid biosynthesis in mammalian cells
Open Access
- 27 September 2022
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Abstract
Major genomic deletions in independent eukaryotic lineages have led to repeated ancestral loss of biosynthesis pathways for nine of the twenty canonical amino acids. While the evolutionary forces driving these polyphyletic deletion events are not well understood, the consequence is that extant metazoans are unable to produce nine essential amino acids (EAAs). Previous studies have highlighted that EAA biosynthesis tends to be more energetically costly, raising the possibility that these pathways were lost from organisms with access to abundant EAAs. It is unclear whether present-day metazoans can reaccept these pathways to resurrect biosynthetic capabilities that were lost long ago or whether evolution has rendered EAA pathways incompatible with metazoan metabolism. Here, we report progress on a large-scale synthetic genomics effort to reestablish EAA biosynthetic functionality in mammalian cells. We designed codon-optimized biosynthesis pathways based on genes mined from Escherichia coli. These pathways were de novo synthesized in 3 kilobase chunks, assembled in yeasto and genomically integrated into a Chinese hamster ovary (CHO) cell line. One synthetic pathway produced valine at a sufficient level for cell viability and proliferation. 13C-tracing verified de novo biosynthesis of valine and further revealed build-up of pathway intermediate 2,3-dihydroxy-3-isovalerate. Increasing the dosage of downstream ilvD boosted pathway performance and allowed for long-term propagation of second-generation cells in valine-free medium at 3.2 days per doubling. This work demonstrates that mammalian metabolism is amenable to restoration of ancient core pathways, paving a path for genome-scale efforts to synthetically restore metabolic functions to the metazoan lineage.Keywords
All Related Versions
Funding Information
- Defense Advanced Research Projects Agency (HR011-17-2-0041)
- National Human Genome Research Institute (RM1 HG009491)
- National Science Foundation (MCB-2032259)
- Burroughs Wellcome Fund (PATH1016691)
- Irma T. Hirschl Trust
- Dean's Fellowship from the Graduate School of Arts and Sciences of Columbia University
- National Institute of Allergy and Infectious Diseases (R01AI132403)
This publication has 34 references indexed in Scilit:
- Pharmaceutically controlled designer circuit for the treatment of the metabolic syndromeProceedings of the National Academy of Sciences, 2012
- Design and Construction of 2A Peptide-Linked Multicistronic VectorsCold Spring Harbor Protocols, 2012
- Amino acids biosynthesis and nitrogen assimilation pathways: a great genomic deletion during eukaryotes evolutionBMC Genomics, 2011
- PhenylketonuriaThe Lancet, 2010
- Self-sufficient control of urate homeostasis in mice by a synthetic circuitNature Biotechnology, 2010
- Positive Selection of Tyrosine Loss in Metazoan EvolutionScience, 2009
- dSLAM analysis of genome-wide genetic interactions in Saccharomyces cerevisiaeMethods, 2007
- Retention and Loss of Amino Acid Biosynthetic Pathways Based on Analysis of Whole-Genome SequencesEukaryotic Cell, 2006
- Recombinase-Mediated Gene Activation and Site-Specific Integration in Mammalian CellsScience, 1991
- THE POPULATION-DEPENDENT REQUIREMENT BY CULTURED MAMMALIAN CELLS FOR METABOLITES WHICH THEY CAN SYNTHESIZEJournal of Experimental Medicine, 1962